Mitochondrial dysfunction: A basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Hernández Aguilera, Anna ^a   Rull, Anna ^a   Rodríguez Gallego, Esther ^a   Riera Borrull, Marta ^a   Luciano Mateo, Fedra ^a   Camps, Jordi ^a   Menéndez, Javier A ^b   Joven, Jorge ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ADENOSINE TRIPHOSPHATE;

ANTIINFLAMMATORY ACTIVITY; BIOENERGY; BIOGENESIS; CALORIC INTAKE; CELL ORGANELLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; FOOD AVAILABILITY; FOOD INTAKE; IMMOBILIZATION; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; HUMAN; IMMUNOLOGY; MITOCHONDRION; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; SMOKING;

NICOTIANA TABACUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; INFLAMMATION; MITOCHONDRIA; OBESITY; SMOKING;

EID: 84875440024     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/135698     Document Type: Review

References (128)

1. Strong K., Mathers C., Leeder S., Beaglehole R., Preventing chronic diseases: how many lives can we save? The Lancet 2005 366 9496 1578 1582 2-s2.0-27544508598 10.1016/S0140-6736(05)67341-2 (Pubitemid 41540116)
2. Cecchini M., Sassi F., Lauer J. A., Lee Y. Y., Guajardo-Barron V., Chisholm D., Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. The Lancet 2010 376 9754 1775 1784 2-s2.0-78650220733 10.1016/S0140-6736(10)61514-0
3. Gaziano T. A., Galea G., Reddy K. S., Scaling up interventions for chronic disease prevention: the evidence. The Lancet 2007 370 9603 1939 1946 2-s2.0-36549031266 10.1016/S0140-6736(07)61697-3 (Pubitemid 350192634)
4. Sims E. A. H., Are there persons who are obese, but metabolically healthy? Metabolism 2001 50 12 1499 1504 10.1053/meta.2001.27213 (Pubitemid 34007425)
5. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., Häring H. U., Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008 168 15 1609 1616 2-s2.0-49449092403 10.1001/archinte.168. 15.1609
6. Iacobellis G., Ribaudo M. C., Zappaterreno A., Iannucci C. V., Leonetti F., Prevalence of uncomplicated obesity in an Italian obese population. Obesity Research 2005 13 6 1116 1122 2-s2.0-26944475620
7. Rull A., Camps J., Alonso-Villaverde C., Joven J., Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism. Mediators of Inflammation 2010 2010 11 2-s2.0-78349279253 10.1155/2010/326580 326580
8. Meigs J. B., Lipinska I., Kathiresan S., Pou K. M., Massaro J. M., Hoffmann U., Vasan R. S., Maurovich-Horvat P., Larson M. G., Keaney J. F., Murabito J. M., O'Donnell C. J., Benjamin E. J., Fox C. S., Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the framingham heart study. Circulation 2007 116 11 1234 1241 2-s2.0-34948902196 10.1161/CIRCULATIONAHA.107.710509 (Pubitemid 47517534)
9. Dowell D., Farley T. A., Prevention of non-communicable diseases in New York City. The Lancet 2012 380 9855 1787 1792 10.1016/S0140-6736(12)60733-8
10. Arduíno D. M., Esteves A. R., Cardoso S. M., Mitochondria drive autophagy pathology via microtubule disassembly: a new hypothesis for Parkinson disease. Autophagy 2013 9 1 112 114
11. Kumar H., Lim H. W., More S. V., Kim B. W., Koppula S., Kim I. S., Choi D. K., The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism. International Journal of Molecular Science 2012 13 8 10478 10504 10.3390/ijms130810478
12. Medina-Gómez G., Mitochondria and endocrine function of adipose tissue. Best Practice & Research Clinical Endocrinology & Metabolism 2012 26 6 791 804 10.1016/j.beem.2012.06.002
13. Pagano G., Castello G., Pallardó F. V., Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials. Free Radical Research 2013 47 2 71 73 10.3109/10715762.2012.748904
14. Ouyang J., Wu M., Huang C., Cao L., Li G., Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: involvement of mitochondrial apoptotic pathways. Oncology Reports 2013 29 1 79 86
15. Osellame L. D., Blacker T. S., Duchen M. R., Cellular and molecular mechanisms of mitochondrial function. Best Practice & Research Clinical Endocrinology & Metabolism 2012 26 6 711 723 10.1016/j.beem.2012.05.003
16. Enache I., Charles A. L., Bouitbir J., Favret F., Zoll J., Metzger D., Oswald-Mammosser M., Geny B., Charloux A., Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension. Molecular and Cellular Biochemistry 2013 373 1-2 161 170 10.1007/s11010-012-1485-6
17. Chol L. W., Metabolic syndrome. Singapore Medical Journal 2011 52 11 779 785
18. Souza M. R., Mde F. D., Medeiros-Filho J. E., Araújo M. S., Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arquivos de Gastroenterologia 2012 49 1 89 96
19. Mirza M. S., Obesity, visceral fat and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterology 2011 2011 11 592404 10.5402/2011/592404
20. Tarantino G., Savastano S., Colao A., Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World Journal of Gastroenterology 2010 16 38 4773 4783 2-s2.0-78049503241 10.3748/wjg.v16.i38.4773
21. Vernochet C., Kahn C. R., Mitochondria, obesity and aging. Aging 2012 4 12 1 2
22. Pintus F., Floris G., Rufini A., Nutrient availability links mitocondria, apoptosis and obesity. Aging 2012 4 11 1 8
23. Rogge M. M., The role of impaired mitochondrial lipid oxidation in obesity. Biological Research for Nursing 2009 10 4 356 373 2-s2.0-63849315875 10.1177/1099800408329408
24. Vinaixa M., Rodríguez M. A., Rull A., Beltrán R., Bladé C., Brezmes J., Cañellas N., Joven J., Correig X., Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. Journal of Proteome Research 2010 9 5 2527 2538 2-s2.0-77952013674 10.1021/pr901203w
25. Rull A., Vinaixa M., Ángel Rodríguez M., Beltrán R., Brezmes J., Cañellas N., Correig X., Joven J., Metabolic phenotyping of genetically modified mice: an NMR metabonomic approach. Biochimie 2009 91 8 1053 1057 2-s2.0-67649424750 10.1016/j.biochi.2009.04.019
26. Joven J., Rull A., Ferré N., Escolà-Gil J. C., Marsillach J., Coll B., Alonso-Villaverde C., Aragones G., Claria J., Camps J., The results in rodent models of atherosclerosis are not interchangeable. The influence of diet and strain. Atherosclerosis 2007 195 2 e85 e92 2-s2.0-36048989420 10.1016/j.atherosclerosis.2007.06.012 (Pubitemid 350087985)
27. Tous M., Ferré N., Camps J., Riu F., Joven J., Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Molecular and Cellular Biochemistry 2005 268 1-2 53 58 2-s2.0-14244253957 10.1007/s11010-005-2997-0 (Pubitemid 40287826)
28. Lindström P., β -cell function in obese-hyperglycemic mice [ob/ob mice]. Advances in Experimental Medicine and Biology 2010 654 463 477 2-s2.0-77953953486 10.1007/978-90-481-3271-3-20
29. de Ferranti S., Mozaffarian D., The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clinical Chemistry 2008 54 6 945 955 2-s2.0-44849116310 10.1373/clinchem.2007.100156 (Pubitemid 351793400)
30. Xu L., Ma X., Cui B., Li X., Ning G., Wang S., Selection of reference genes for qRT-PCR in high fat diet-induced hepatic steatosis mice model. Molecular Biotechnology 2011 48 3 255 262 10.1007/s12033-010-9366-2
31. Machado M. V., Coutinho J., Carepa F., Costa A., Proença H., Cortez-Pinto H., How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology 2012 24 10 1166 1172 10.1097/MEG.0b013e32835609b0
32. Cohen J. C., Horton J. D., Hobbs H. H., Human fatty liver disease: old questions and new insights. Science 2011 332 6037 1519 1523 2-s2.0-79959517565 10.1126/science.1204265
33. Pagliassotti M. J., Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annual Review of Nutrition 2012 32 17 33 10.1146/annurev-nutr- 071811-150644
34. Neel J. V., Diabetes mellitus a "thrifty" genotype rendered detrimental by 'progress'? The American Journal of Human Genetics 1962 14 352 353
35. Neel J. V., Update to 'The study of natural selection in primitive and civilized human populations'. Human Biology 1989 61 5-6 811 823 2-s2.0-0024918708 (Pubitemid 20146104)
36. Frisancho A. R., Reduced rate of fat oxidation: a metabolic pathway to obesity in the developing nations. The American Journal of Human Biology 2003 15 4 522 532 2-s2.0-0038388269 10.1002/ajhb.10191 (Pubitemid 36818001)
37. Speakman J. R., A novel non-adaptive scenario explaining the genetic pre-disposition to obesity: the "predation release" hypothesis. Cell Metabolism 2007 6 1 5 12 10.1016/j.cmet.2007.06.004 (Pubitemid 46995779)
38. Speakman J. R., O'Rahilly S., Fat: an evolving issue. Disease Models and Mechanisms 2012 5 5 569 573 10.1242/dmm.010553
39. Rius B., López-Vicario C., González-Périz A., Morán-Salvador E., García-Alonso V., Clária J., Titos E., Resolution of inflammation in obesity-induced liver disease. Frontiers in Immunology 2012 3 article 257 10.3389/fimmu.2012.00257
40. Paul A., Calleja L., Camps J., Osada J., Vilella E., Ferré N., Mayayo E., Joven J., The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sciences 2000 68 4 457 465 2-s2.0-0034671783 10.1016/S0024-3205(00)00950-4 (Pubitemid 32011897)
41. Tous M., Ferré N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., Camps J., Joven J., Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochemical and Biophysical Research Communications 2006 340 4 1078 1084 2-s2.0-30544434288 10.1016/j.bbrc.2005.12.109 (Pubitemid 43083388)
42. Masana L., Camprubi M., Sarda P., Sola R., Joven J., Turner P. R., The mediterranean-type diet: is there a need for further modification? The American Journal of Clinical Nutrition 1991 53 4 886 889 2-s2.0-0025765939 (Pubitemid 21898851)
43. Rolo A. P., Teodoro J. S., Palmeira C. M., Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2012 52 1 59 69 10.1016/j.freeradbiomed.2011.10.003
44. Mlinar B., Marc J., New insights into adipose tissue dysfunction in insulin resistance. Clinical Chemistry and Laboratory Medicine 2011 29 12 1925 1935
45. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 117 1 175 184 2-s2.0-33846026712 10.1172/JCI29881 (Pubitemid 46048464)
46. + adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 2010 59 5 1171 1181 2-s2.0-77951822653 10.2337/db09-1402
47. + adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010 59 7 1648 1656 2-s2.0-77954249680 10.2337/db09-0287
48. Rull A., Beltrán-Debón R., Aragonès G., Rodríguez-Sanabria F., Alonso-Villaverde C., Camps J., Joven J., Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet. Cytokine 2010 50 2 121 128 10.1016/j.cyto.2010.02.010
49. Batista M. L., Peres S. B., McDonald M. E., Alcantara P. S., Olivan M., Otoch J. P., Farmer S. R., Seelaender M., Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine 2012 57 1 9 16 10.1016/j.cyto.2011.10.008
50. Rull A., Escolà-Gil J. C., Julve J., Rotllan N., Calpe-Berdiel L., Coll B., Aragonès G., Marsillach J., Alonso-Villaverde C., Camps J., Blanco-Vaca F., Joven J., Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism. Experimental and Molecular Pathology 2007 83 3 361 366 2-s2.0-36048979016 10.1016/j.yexmp.2007.08.003 (Pubitemid 350087023)
51. Coll B., Alonso-Villaverde C., Joven J., Monocyte chemoattractant protein-1 and atherosclerosis: Is there room for an additional biomarker? Clinica Chimica Acta 2007 383 1-2 21 29 2-s2.0-34347383594 10.1016/j.cca.2007. 04.019 (Pubitemid 47018251)
52. Westermann B., Mitochondrial fusion and fission in cell life and death. Nature Reviews Molecular Cell Biology 2010 11 12 872 884 2-s2.0-78649413837 10.1038/nrm3013
53. Chan D. C., Mitochondrial fusion and fission in mammals. Annual Review of Cell and Developmental Biology 2006 22 79 99 2-s2.0-33750445482 10.1146/annurev.cellbio.22.010305.104638
54. Margineantu D. H., Cox W. G., Sundell L., Sherwood S. W., Beechem J. M., Capaldi R. A., Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion 2002 1 5 425 435 2-s2.0-0036242518 10.1016/S1567-7249(02)00006-5 (Pubitemid 34461241)
55. Frazier A. E., Kiu C., Stojanovski D., Hoogenraad N. J., Ryan M. T., Mitochondrial morphology and distribution in mammalian cells. Biological Chemistry 2006 387 12 1551 1558 2-s2.0-33751518572 10.1515/BC.2006.193 (Pubitemid 44837579)
56. Westermann B., Bioenergetic role of mitochondrial fusion and fission. Biochimica et Biophysica Acta 2012 1817 10 1833 1838 10.1016/j.bbabio.2012.02. 033
57. Chang J. C., Kou S. J., Lin W. T., Liu C. S., Regulatory role of mitochondria in oxidative stress and atherosclerosis. World Journal of Cardiology 2010 2 6 150 159 10.4330/wjc.v2.i6.150
58. Chan D. C., Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006 125 7 1241 1252 2-s2.0-33745274726 10.1016/j.cell.2006. 06.010 (Pubitemid 43929096)
59. Fearon K. C., Glass D. J., Guttridge D. C., Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metabolism 2012 16 2 153 166 10.1016/j.cmet.2012.06.011
60. Lira F. S., Carnevali L. C., Zanchi N. E., Santos R. V. T., Lavoie J. M., Seelaender M., Exercise intensity modulation of hepatic lipid metabolism. Journal of Nutrition and Metabolism 2012 2012 8 809576 10.1155/2012/809576
61. Lokireddy S., Wijesoma I. W., Teng S., Bonala S., Gluckman P. D., McFarlane C., Sharma M., Kambadur R., The ubiquitin ligase mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metabolism 2012 16 5 613 624 10.1016/j.cmet.2012.10.005
62. Banasch M., Ellrichmann M., Tannapfel A., Schmidt W. E., Goetze O., The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. European Journal of Medical Research 2011 16 6 258 264 2-s2.0-79960232654
63. Dröge W., Schipper H. M., Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007 6 3 361 370 2-s2.0-34249104544 10.1111/j.1474-9726.2007.00294.x (Pubitemid 46785141)
64. Witte M. E., Geurts J. J. G., de Vries H. E., van der Valk P., van Horssen J., Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 2010 10 5 411 418 2-s2.0-77955385260 10.1016/j.mito.2010.05.014
65. Menendez J. A., Cufi S., Oliveras-Ferraros C., Vellon L., Joven J., Vazquez-Martin A., Gerosuppressant metformin: less is more. Aging 2011 3 4 348 362
66. Rattan S. I., Anti-ageing strategies: prevention or therapy? Showing ageing from within. EMBO Reports 2005 6 S25 S29 2-s2.0-24744459076
67. Saprunova V. B., Lelekova M. A., Kolosova N. G., Bakeeva L. E., SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of wistar and OXYS rats. Biochemistry 2012 77 6 648 658 10.1134/S0006297912060120
68. Liu T. F., Brown C. M., El Gazzar M., McPhail L., Millet P., Rao A., Vachharajani V. T., Yoza B. K., McCall C. E., Fueling the flame: bioenergy couples metabolism and inflammation. Journal of Leukocyte Biology 2012 92 3 499 507 10.1189/jlb.0212078
69. Profumo E., Buttari B., Petrone L., Straface E., Gambardella L., Pietraforte D., Genuini I., Capoano R., Salvati B., Malorni W., Riganò R., Redox imbalance of red blood cells impacts T lymphocyte homeostasis: implication in carotid atherosclerosis. Journal of Thrombosis and Haemostasis 2011 106 6 1117 1126 10.1160/TH11-02-0110
70. Kusminski C. M., Holland W. L., Sun K., Park J., Spurgin S. B., Lin Y., Askew G. R., Simcox J. A., McClain D. A., Li C., Scherer P. E., MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptative process that preserves insulin sensitivity in obesity. Nature Medicine 2012 18 10 1539 1549 10.1038/nm.2899
71. Zorzano A., Liesa M., Palacín M., Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. International Journal of Biochemistry and Cell Biology 2009 41 10 1846 1854 2-s2.0-68949116271 10.1016/j.biocel.2009.02.004
72. Aguer C., Harper M. E., Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects. Best Practice & Research Clinical Endocrinology & Metabolism 2012 26 6 805 819 10.1016/j.beem.2012.06.001
73. Ma Z. A., The role of peroxidation of mitochondrial membrane phospholipids in pancreatic β -cell failure. Current Diabetes Reviews 2012 8 1 69 75 10.2174/157339912798829232
74. Tang C., Koulajian K., Schuiki I., Zhang L., Desai T., Ivovic A., Wang P., Robson-Doucette C., Wheeler M. B., Minassian B., Volchuk A., Giacca A., Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. Diabetologia 2012 55 5 1366 1379 10.1007/s00125-012-2474-8
75. Brondani A. Lde., Assmann T. S., Duarte G. C., Gross J. L., Canani L. H., Crispim D., The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus. Arquivos Brasileiros de Endocrinologia e Metabologia 2012 56 4 215 225
76. Fedorenko A., Lishko P. V., Kirichok Y., Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 2012 151 2 400 413 10.1016/j.cell.2012.09.010
77. Cannon B., Nedergaard J., Cell biology: neither brown nor white. Nature 2012 488 7411 286 287 10.1038/488286a
78. Grattagliano I., de Bari O., Bernardo T. C., Oliveira P. J., Wang D. Q., Portincasa P., Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation. Clinical Biochemistry 2012 45 9 610 618 10.1016/j.clinbiochem.2012.03.024
79. Serviddio G., Bellanti F., Vendemiale G., Altomare E., Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Review of Gastroenterology and Hepatology 2011 5 2 233 244 2-s2.0-79954452625 10.1586/egh.11.11
80. Sadler N. C., Angel T. E., Lewis M. P., Activity-based protein profiling reveals mitochondrial oxidative enzyme impairment and restoration in diet-induced obese mice. PLoS ONE 2012 7 10 e47996 10.1371/journal.pone.0047996
81. Carrer M., Liu N., Grueter C. E., Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378. Proceedings of the National Academy of Sciences of the United States of America 2012 109 38 15330 15335 10.1073/pnas.1207605109
82. Karelis A. D., Faraj M., Bastard J. P., St-Pierre D. H., Brochu M., Prud'homme D., Rabasa-Lhoret R., The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism 2005 90 7 4145 4150 2-s2.0-23044454515 10.1210/jc.2005-0482 (Pubitemid 41058189)
83. Kusminski C. M., Scherer P. E., Mitochondrial dysfunction in white adipose tissue. Trends in Endocrinology and Metabolism 2012 23 9 435 443 10.1016/j.tem.2012.06.004
84. Zorzano A., Hernández-Alvarez M. I., Palacín M., Mingrone G., Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1 α or PGC-1 β and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochimica et Biophysica Acta 2010 1797 6-7 1028 1033 2-s2.0-77953807425 10.1016/j.bbabio.2010.02.017
85. Zorzano A., Sebastián D., Segalés J., Palacín M., The molecular machinery of mitochondrial fusion and fission: an opportunity for drug discovery? Current Opinion in Drug Discovery and Development 2009 12 5 597 606 2-s2.0-70149097538
86. Chen X. J., Butow R. A., The organization and inheritance of the mitochondrial genome. Nature Reviews Genetics 2005 6 11 815 825 10.1038/nrg1708
87. Distler A. M., Kerner J., Hoppel C. L., Proteomics of mitochondrial inner and outer membranes. Proteomics 2008 8 19 4066 4082 2-s2.0-55749085987 10.1002/pmic.200800102
88. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nuñez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H. U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G., Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death and Differentiation 2012 19 107 120 2-s2.0-79960237427 10.1038/cdd.2011.96
89. Joza N., Oudit G. Y., Brown D., Bénit P., Kassiri Z., Vahsen N., Benoit L., Patel M. M., Nowikovsky K., Vassault A., Backx P. H., Wada T., Kroemer G., Rustin P., Penninger J. M., Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Molecular and Cellular Biology 2005 25 23 10261 10272 2-s2.0-27944475065 10.1128/MCB.25.23.10261-10272.2005 (Pubitemid 41681953)
90. Speakman J. R., Mitchell S. E., Caloric restriction. Molecular Aspects of Medicine 2011 32 3 159 221 10.1016/j.mam.2011.07.001
91. Raffaello A., Rizzuto R., Mitochondrial longevity pathways. Biochimica et Biophysica Acta 2011 1813 1 260 268 2-s2.0-78650736695 10.1016/j.bbamcr.2010. 10.007
92. Alkhouri N., Gornicka A., Berk M. P., Thapaliya S., Dixon L. J., Kashyap S., Schauer P. R., Feldstein A. E., Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. The Journal of Biological Chemistry 2010 285 5 3428 3438 2-s2.0-77449083262 10.1074/jbc.M109.074252
93. Salt I. P., Palmer T. M., Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opinion on Investigational Drugs 2012 21 8 1155 1167 10.1517/13543784.2012.696609
94. Boyle J. G., Logan P. J., Jones G. C., Small M., Sattar N., Connell J. M. C., Cleland S. J., Salt I. P., AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 2011 54 7 1799 1809 2-s2.0-79959705713 10.1007/s00125-011-2126-4
95. Sullivan J. E., Brocklehurst K. J., Marley A. E., Carey F., Carling D., Beri R. K., Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Letters 1994 353 1 33 36 2-s2.0-0028073143 10.1016/0014-5793(94)01006-4 (Pubitemid 24312538)
96. Yin W., Mu J., Birnbaum M. J., Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. The Journal of Biological Chemistry 2003 278 44 43074 43080 2-s2.0-0242384915 10.1074/jbc.M308484200 (Pubitemid 37345923)
97. Gaidhu M. P., Fediuc S., Ceddia R. B., 5-Aminoimidazole-4-carboxamide-1- β -D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. The Journal of Biological Chemistry 2006 281 36 25956 25964 2-s2.0-33748752150 10.1074/jbc.M602992200 (Pubitemid 44401801)
98. Gaidhu M. P., Fediuc S., Anthony N. M., So M., Mirpourian M., Perry R. L. S., Ceddia R. B., Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. Journal of Lipid Research 2009 50 4 704 715 2-s2.0-65349152290 10.1194/jlr.M800480-JLR200
99. Turer A. T., Scherer P. E., Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012 55 9 2319 2326 10.1007/s00125-012-2598- x
100. Galic S., Fullerton M. D., Schertzer J. D., Hematopoietic AMPK β 1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. Journal of Clinical Investigation 2011 121 12 4903 4915 10.1172/JCI58577
101. Vila-Bedmar R., Lorenzo M., Fernández-Veledo S., Adenosine 5′-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 2010 151 3 980 992 2-s2.0-77149154335 10.1210/en.2009-0810
102. Horakova O., Medrikova D., van Schothorst E. M., Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice. PLoS ONE 2012 7 8 e43764 10.1371/journal.pone.0043764
103. To V. T., Hüttl T. P., Lang R., Piotrowski K., Parhofer K. G., Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Experimental and Clinical Endocrinology and Diabetes 2012 120 9 547 552 10.1055/s-0032-1323738
104. Heneghan H. M., Nissen S., Schauer P. R., Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. Current Atherosclerosis Reports 2012 14 6 579 587 10.1007/s11883-012-0285-5
105. Luke A., O'Neill J., Hardie D., Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013 493 346 355 10.1038/nature11862
106. Finelli C., Tarantino G., Is there any consensus as to what diet of lifestyle approach is the right one for NAFLD patients? Journal of Gastrointestinal and Liver Diseases 2012 21 293 302
107. Joven J., Menéndez J., Fernandez-Sender L., Metformin: a cheap and well-tolerated drug that provides benefits for viral infections. HIV Medicine 2012 10.1111/hiv.12000
108. Del Barco S., Vazquez-Martin A., Cufí S., Oliveras-Ferraros C., Bosch-Barrera J., Joven J., Martin-Castillo B., Menendez J. A., Metformin: multi-faceted protection against cancer. Oncotarget 2011 2 12 896 917
109. Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F., Cellular and molecular mechanisms of metformin: an overview. Clinical Science 2012 122 6 253 270 10.1042/CS20110386
110. Nair S., Diehl A. M., Wiseman M., Farr G. H., Perrillo R. P., Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Alimentary Pharmacology and Therapeutics 2004 20 1 23 28 2-s2.0-3142670354 10.1111/j.1365-2036.2004.02025.x (Pubitemid 38938715)
111. Duseja A., Das A., Dhiman R. K., Chawla Y. K., Thumburu K. K., Bhadada S., Bhansali A., Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Annals of Hepatology 2007 6 4 222 226 2-s2.0-37549047166
112. Haukeland J. W., Konopsi Z., Eggesbo H. B., von Volkmann H. L., Raschpichler G., Bjøro K., Haaland T., Løberg E. M., Birkeland K., Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scandinavian Journal of Gastroenterology 2009 44 7 853 860
113. Foretz M., Hébrard S., Leclerc J., Zarrinpashneh E., Soty M., Mithieux G., Sakamoto K., Andreelli F., Viollet B., Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Journal of Clinical Investigation 2010 120 7 2355 2369 2-s2.0-77954933558 10.1172/JCI40671
114. Owen M. R., Doran E., Halestrap A. P., Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 2000 348 3 607 614 2-s2.0-0034659785 10.1042/0264-6021:3480607 (Pubitemid 30410251)
115. Ahn B. H., Kim H. S., Song S., In H. L., Liu J., Vassilopoulos A., Deng C. X., Finkel T., A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14447 14452 2-s2.0-55749084738 10.1073/pnas.0803790105
116. Kong X., Wang R., Xue Y., Liu X., Zhang H., Chen Y., Fang F., Chang Y., Sirtuin 3, a new target of PGC-1 α plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010 5 7 2-s2.0-77955347446 10.1371/journal.pone.0011707 e11707
117. Buler M., Aatsinki S. M., Izzi V., Hakkola J., Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism. PLoS ONE 2012 7 11 e49863 10.1371/journal.pone.0049863
118. Caton P. W., Nayuni N. K., Kieswich J., Khan N. Q., Yaqoob M. M., Corder R., Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. Journal of Endocrinology 2010 205 1 97 106 2-s2.0-77949493599 10.1677/JOE-09-0345
119. Corominas-Faja B., Quirantes-Piné R., Oliveras-Ferraros C., Vazquez-Martin A., Cufí S., Martin-Castillo B., Micol V., Joven J., Segura-Carretero A., Menendez J. A., Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging 2012 4 7 480 498
120. Beltrán-Debón R., Rull A., Rodríguez-Sanabria F., Iswaldi I., Herranz-López M., Aragonès G., Camps J., Alonso-Villaverde C., Menéndez J. A., Micol V., Segura-Carretero A., Joven J., Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. Phytomedicine 2011 18 5 414 424 2-s2.0-79952736960 10.1016/j.phymed.2010.11.008
121. Joven J., Rull A., Rodríguez-Gallego E., Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism. Food and Chemical Toxicology 2013 51 267 279 10.1016/j.fct.2012.10. 004
122. Joven J., Espinel E., Rull A., Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochimica et Biophysica Acta 1820 7 894 899 10.1016/j.bbagen.2012.03.020
123. Segura-Carretero A., Puertas-Mejía M. A., Cortacero-Ramírez S., Beltrán R., Alonso-Villaverde C., Joven J., Dinelli G., Fernández-Gutiérrez A., Selective extraction, separation, and identification of anthocyanins from Hibiscus sabdariffa L. using solid phase extraction-capillary electrophoresis-mass spectrometry (time-of-flight/ion trap). Electrophoresis 2008 29 13 2852 2861 2-s2.0-47549100204 10.1002/elps.200700819 (Pubitemid 352006118)
124. Johnson S. C., Rabinovitch P. S., Kaeberlein M., mTOR is a key modulator of ageing and age-related disease. Nature 2013 493 338 345 10.1038/nature11861
125. Herranz-López M., Fernández-Arroyo S., Pérez-Sanchez A., Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine 2012 19 3-4 253 261 10.1016/j.phymed.2011.12.001
126. Virtue S., Vidal-Puig A., It's not how fat you are, it's what you do with it that counts. PLoS Biology 2008 6 9, article e237 2-s2.0-55549130805 10.1371/journal.pbio.0060237
127. Singh R., Cuervo A. M., Lipophagy: connecting autophagy and lipid metabolism. International Journal of Cell Biology 2012 2012 12 282041 10.1155/2012/282041
128. Jansen H. J., van Essen P., Koenen T., Joosten L. A., Netea M. G., Tack C. J., Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 2012 153 12 5866 5874 10.1210/en.2012-1625